Download PDF
Thromb Haemost 1995; 74(01): 411-414
DOI: 10.1055/s-0038-1642713
Symposium
Vaascular Growth Factor
Schattauer GmbH Stuttgart

Molecular Mechanisms of Fibroblast Growth Factor-1 Traffick, Signaling and Release

T Maciag
Department of Molecular Biology, Holland Laboratory, American Red Cross, Rockville, MD, USA
,
R E Friesel
Department of Molecular Biology, Holland Laboratory, American Red Cross, Rockville, MD, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
09 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Fdkman J. Angiogenesis and breast cancer. J din Oncol 1994; 12: 441-443
    PubMedGoogle Scholar
  • 2 Schott RJ, Morrow LA. Growth factors and angiogenesis. Cardiovasc Res 1993; 27: 1155-1161
    CrossrefPubMedGoogle Scholar
  • 3 Weinstatsaslow D, Steeg PS. Angiogenesis and colonization in the tumor metastatic process -Basic and applied advances. FASEB J 1994; 8: 401-407
    CrossrefPubMedGoogle Scholar
  • 4 Freitas I, Baronzio F. Neglected factors in cancer treatment - Cellular interactions and dynamic microenvironment in solid tumors. Anticancer Res 1994; 14: 1097-1101
    PubMedGoogle Scholar
  • 5 Leek RD, Harris AL, Lewis CE. Cytokine networks in solid human tumors - Regulation of angiogenesis. J Leukocyte Biol 1994; 56: 423-435
    CrossrefPubMedGoogle Scholar
  • 6 Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994; 79: 185-188
    CrossrefPubMedGoogle Scholar
  • 7 Pepper MS, Vassalli JD, Wilks JW, Schweigerer L, Orci L, Montesano R. Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis. J Cell Biochem 1994; 55: 419-134
    CrossrefPubMedGoogle Scholar
  • 8 Burrows FJ, Thorpe PE. Vascular targeting - A new approach to the therapy of solid tumors. Pharmacol Ther 1994; 64: 155-174
    CrossrefPubMedGoogle Scholar
  • 9 Diazflores L, Gutierrez R, Varela H. Angiogenesis - An update. Histol & Histopathol 1994; 9: 807-843
    PubMedGoogle Scholar
  • 10 Damato RJ, Loughnan MS, Flynn E, Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 1994; 91: 4082-4085
    CrossrefPubMedGoogle Scholar
  • 11 O’Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao YH, Sage EH, Folkman J. Angiostatin-A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315-328
    CrossrefPubMedGoogle Scholar
  • 12 Hu DE, Hori Y, Presta M, Gresham GA, Fan TP. Inhibition of angiogenesis in rats by IL-1 receptor antagonist and selected cytokine antibodies. Inflammation 1994; 18: 45-58
    CrossrefPubMedGoogle Scholar
  • 13 Norioka K, Mi taka T, Mochizuki Y, Hara M, Kawagoe M, Nakamura H. Interaction of interleukin-1 and interferon-gamma on fibroblast growth factor-induced angiogenesis. Japanese J Cancer Res 1994; 85: 522-529
    PubMedGoogle Scholar
  • 14 Fantl WJ, Johnson DE, Williams LT. Signaling by receptor tyrosine kinases. Annu Rev Biochem 1993; 62: 453-482
    CrossrefPubMedGoogle Scholar
  • 15 Burgess WH, and Winkles JA. The fibroblast growth factor family: Multifunctional regulators of cell proliferation. Oxford:Oxford University Press; 1994: 155-218
    Google Scholar
  • 16 Pantoliano MW, Horlick RA, Springer BA, Vandyk DE, Tobery T, Wetmore DR, Lear JD, Nahapetian AT, Bradley JD, Sisk WP. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry 1994; 33: 10229-10248
    CrossrefPubMedGoogle Scholar
  • 17 Stachowiak MK, Moffett J, Joy A, Puchacz E, Florkiewicz R, Stachowiak EK. Regulation of bFGF gene expression and subcellular distribution of bFGF protein in adrenal medullary cells. J Cell Biol 1994; 127: 203-223
    CrossrefPubMedGoogle Scholar
  • 18 Jans DA. Nuclear signaling pathways for polypeptide ligands and their membrane receptors. FASEB J 1994; 8: 841-847
    CrossrefPubMedGoogle Scholar
  • 19 Yeoman LC. An autocrine model for cell-associated and matrix-associated fibroblast growth factor. Oncology Res 1993; 5: 489-499
    PubMedGoogle Scholar
  • 20 Plate KH, Breier G, Risau W. Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 1994; 4: 207-218
    CrossrefPubMedGoogle Scholar
  • 21 Senger DR, Vandewater L, Brown LF, Nagy JA, Yeo KT, Yeo TK, Berse B, Jackman RW, Dvorak AM, Dvorak HF. Vascular permeability factor (VPF, VEGF) in tumor biology. . Cancer Metastasis Rev 1993; 12: 303-324
    CrossrefPubMedGoogle Scholar
  • 22 Moroianu J, Riordan JF. Nuclear translocation of angiogenic proteins in endothelial cells: An essential step in angiogenesis. Biochemistry 1994; 33: 12535-12539
    CrossrefPubMedGoogle Scholar
  • 23 Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989; 58: 575-606
    CrossrefPubMedGoogle Scholar
  • 24 Friesel RE, Maciag T. Molecular mechanisms of angiogenesis: Fibroblast growth factor signal transduction. FASEB J. 1995 (In Press)
    PubMedGoogle Scholar
  • 25 Miyamoto M, Naruo K- I, Seko C, Matsumoto S, Kondo T, Kurokawa T. Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol Cell Biol 1993; 13: 4251-4259
    CrossrefPubMedGoogle Scholar
  • 26 Mason U. The ins and outs of fibroblast growth factors. Cell 1994; 78: 547-552
    CrossrefPubMedGoogle Scholar
  • 27 Quarto N, Talarico D, Florkiewicz R, Rifkin DB. Selective expression of high molecular weight basic fibroblast growth factor confers a unique phenotype to NIH 3T3 cells. Cell Regul 1991; 2: 699-708
    CrossrefPubMedGoogle Scholar
  • 28 Zhan X, Hu XG, Friedman S, Maciag T. Analysis of Endogenous and Exogenous Nuclear Translocation of Fibroblast Growth Factor-1 in NIH 3T3 Cells. Biochem Biophys Res Commun 1992; 188: 982-991
    CrossrefPubMedGoogle Scholar
  • 29 Zhan X, Hu X, Friesel R, Maciag T. Long term growth factor exposure and differential tyrosine phosphorylation are required for DNA synthesis in BALB/c 3T3 cells. J Biol Chem 1993; 268: 9611-9620
    PubMedGoogle Scholar
  • 30 Wiedlocha A, Falnes PO, Madshus IH, Sandvig K, Olsnes S. Dual mode of signal transduction by externally added acidic fibroblast growth factor. Cell 1994; 76: 1039-1051
    CrossrefPubMedGoogle Scholar
  • 31 Friedman S, Zhan X, Maciag T. Mutagenesis of the nuclear localization sequence in FGF-1 alters protein stability but not mitogenic activity. Biochem Biophys Res Commun 1994; 198: 1203-1208
    CrossrefPubMedGoogle Scholar
  • 32 Prudovsky I, Savion N, Zhan X, Friesel R, Xu J, Hou J, Mckeehan WL, Maciag T. Intact and functional fibroblast growth factor (FGF) receptor-1 trafficks near the nucleus in response to FGF-1. J Biol Chem 1994; 269: 31720-31724
    PubMedGoogle Scholar
  • 33 Maciag T, Zhan X, Garfinkel S, Friedman S, Pmdovsky I, Jackson A, Wessendorf J, Hu X, Gamble S, Shi J, Brown S, Tarantini F, Zimrin A. Novel mechanisms of fibroblast growth factor-1 function. Recent Prog Hoim Res 1993; 49: 105-123
    PubMedGoogle Scholar
  • 34 Kiefer P, Acland P, Pappin D, Peters G, Dickson C. Competition between nuclear localization and secretory signals determines the intracellular fate of a single CUG-initiated form of FGF-3. EMBO J 1994; 13: 4126-4136
    PubMedGoogle Scholar
  • 35 Zhan X, Hu X, Hampton B, Burgess WH, Friesel R, Maciag T. Murine cortactin is phosphorylated in response to fibroblast growth factor-1 on tyrosine residues late in the G1 phase of the BALB/c 3T3 cell cycle. . J BiolChem 1993; 268: 24427-24431
    PubMedGoogle Scholar
  • 36 Wu H, Reynolds AB, Kanner SB, Vines RR, Parsons JT. Identification and characterization of a novel cytoskeleton-associated pp60src substrate. Mol Cell Biol 1991; 11: 5113-5124
    CrossrefPubMedGoogle Scholar
  • 37 Wu H, Parsons JT. Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J Cell Biol 1993; 120: 1417-1426
    CrossrefPubMedGoogle Scholar
  • 38 Zhan X, Plourde C, Hu X, Friesel R, Maciag T. Association of fibroblast growth factor receptor-1 with c-Src correlates with association between c-Src and cortactin. J Biol Chem 1994; 269: 20221-20224
    PubMedGoogle Scholar
  • 39 David-Pfeuty T, Bagrodia S, Shalloway D. Differential localization patterns of myristoylated and non-myristoylated c-Src proteins in interphase and mitotic c-Src overexpresser cells. . J Cell Sci 1993; 105: 613-628
    PubMedGoogle Scholar
  • 40 Howell BW, Cooper JA. Csk suppression of Src involves movement of Csk to sites of Src activity. Mol Cell Biol 1994; 14: 5402-5411
    CrossrefPubMedGoogle Scholar
  • 41 Schaller MD, Hildebrand JD, Shannon JD, Fox JW, Vines RR, Parsons JT. Autophosphorylation of the focal adhesion site kinase, ppl25fax, directs SH2-dependent binding of pp60src. Mol Cell Biol 1994; 14: 1680-1688
    CrossrefPubMedGoogle Scholar
  • 42 Mason I. Do adhesion molecules signal via FGF receptors. Curr Biol 1994; 4: 1158-1161
    CrossrefPubMedGoogle Scholar
  • 43 Burgess WH, Shaheen AM, Ravera M, Jaye M, Donohue PJ, Wipkles JA. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue. . J Cell Biol 1990; 111: 2129-2138
    CrossrefPubMedGoogle Scholar
  • 44 Imamura T, Friedman SA, Gamble S, Tokita Y, Opalenik SR, Thompson JA, Maciag T. Identification of the domain within fibroblast growth factor-1 responsible for heparin-dependence. Biochim Biophys Acta. 1995 (In Press)
    PubMedGoogle Scholar
  • 45 Kan M, Wang F, Xu J, Crabb J W, Hou J, Mckeehan WL. An Essential Heparin-Binding Domain in the Fibroblast Growth Factor Receptor Kinase. Science 1993; 259: 1918-1921
    CrossrefPubMedGoogle Scholar
  • 46 Rapraeger AC, Krafka A, Olwin BB. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 1991; 252: 1705-1708
    CrossrefPubMedGoogle Scholar
  • 47 Yayon A, Klagsbrun M, Esko JD, Leder P, Omitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991; 64: 841-848
    CrossrefPubMedGoogle Scholar
  • 48 Roghani M, Mansukhani A, Dell’Era P, Bellosta P, Basilico C, Rifkin DB, Moscatelli D. Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J Biol Chem 1994; 269: 3976-3984
    PubMedGoogle Scholar
  • 49 Talarico D, Basilico C. The K-fgf/hst oncogene induces transformation through an autocrine mechanism that requires extracellular stimulation of the mitogenic pathway. Mol Cell Biol 1991; 11: 1138-1145
    CrossrefPubMedGoogle Scholar
  • 50 Rogelj S, Weinberg RA, Fanning P, Klagsbrun M. Basic fibroblast growth factorfused to a signal peptide transforms cells. Nature 1988; 331: 173-175
    CrossrefPubMedGoogle Scholar
  • 51 Forough R, Zhan X, MacPhee M, Friedman S, Engleka KA, Sayers T, Wiltrout RH, Maciag T. Differential transforming abilities of non-secreted and secreted forms of human Fibroblast Growth Factor-1. J Biol Chem 1993; 268: 2960-2968
    PubMedGoogle Scholar
  • 52 Robinson ML, Overbeek PA, Verran DJ, Grizzle WE, Stockard CR, Friesel R, Maciag T, Thompson JA. Extracellular FGF-1 acts as a lens differentiation factor in transgenic mice. Development 1995; 121: 505-514
    PubMedGoogle Scholar
  • 53 Nabel EG, Yang Z-Y, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T, Nabel GJ. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature 1993; 362: 844-846
    CrossrefPubMedGoogle Scholar
  • 54 Jackson A, Friedman S, Zhan X, Engleka KA, Forough R, Maciag T. Heat shock induces the release of Fibroblast Growth Factor- 1 from NIH-3T3 cels. Proc Natl Acad Sci USA 1992; 89: 10691-10695
    CrossrefPubMedGoogle Scholar
  • 55 Jackson A, Tarantini F, Gamble S, Friedman S, Maciag T. Release of fibroblast growth factor-1 from NIH 3T3 cells in response to temperature involves the function of cysteine residues. J Biol Chem 1995; 270: 33-36
    CrossrefPubMedGoogle Scholar
  • 56 Engleka KA, Maciag T. Inactivation of human fibroblast growth factor-1 (FGF-1) activity by interaction with copper ions involves FGF-1 dimer formation induced by copper-catalyzed oxidation. J Biol Chem 1992; 267: 11307-11315
    PubMedGoogle Scholar